Analysen zu Novo Nordisk
| 09.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.10.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.09.25 | Novo Nordisk Outperform | Bernstein Research | |
| 10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 21.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.07.25 | Novo Nordisk Buy | UBS AG | |
| 18.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.07.25 | Novo Nordisk Buy | UBS AG | |
| 11.07.25 | Novo Nordisk Buy | UBS AG | |
| 09.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.07.25 | Novo Nordisk Buy | UBS AG | |
| 01.07.25 | Novo Nordisk Buy | UBS AG | |
| 30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | Novo Nordisk Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.25 | Novo Nordisk Buy | UBS AG | |
| 23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
| 23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.25 | Novo Nordisk Buy | UBS AG | |
| 17.06.25 | Novo Nordisk Buy | UBS AG | |
| 16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.06.25 | Novo Nordisk Buy | UBS AG | |
| 09.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.06.25 | Novo Nordisk Buy | UBS AG | |
| 02.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.05.25 | Novo Nordisk Buy | UBS AG | |
| 19.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. |
Aktuelle Aktienanalysen
| 27.02.26 | AXA Overweight | JP Morgan Chase & Co. | |
| 27.02.26 | Allianz Sector Perform | RBC Capital Markets | |
| 27.02.26 | Eni Underweight | JP Morgan Chase & Co. | |
| 27.02.26 | Schneider Electric Outperform | Bernstein Research | |
| 27.02.26 | Münchener Rückversicherungs-Gesellschaft Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.26 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 27.02.26 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 27.02.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 27.02.26 | Swiss Re Underperform | RBC Capital Markets | |
| 27.02.26 | Swiss Re Hold | Jefferies & Company Inc. | |
| 27.02.26 | HENSOLDT Buy | Deutsche Bank AG | |
| 27.02.26 | KION GROUP Buy | Deutsche Bank AG | |
| 27.02.26 | London Stock Exchange Buy | Deutsche Bank AG | |
| 27.02.26 | AXA Buy | Deutsche Bank AG | |
| 27.02.26 | Rolls-Royce Buy | Deutsche Bank AG | |
| 27.02.26 | Scout24 Buy | Deutsche Bank AG | |
| 27.02.26 | Allianz Hold | Deutsche Bank AG | |
| 27.02.26 | arGEN-X Hold | Deutsche Bank AG | |
| 27.02.26 | Stellantis Hold | Deutsche Bank AG | |
| 27.02.26 | Valeo Hold | Deutsche Bank AG | |
| 27.02.26 | Schneider Electric Equal Weight | Barclays Capital | |
| 27.02.26 | Alzchem Group Buy | Warburg Research | |
| 27.02.26 | Delivery Hero Buy | Jefferies & Company Inc. | |
| 27.02.26 | Delivery Hero Outperform | RBC Capital Markets | |
| 27.02.26 | BASF Underweight | JP Morgan Chase & Co. | |
| 27.02.26 | Delivery Hero Overweight | Barclays Capital | |
| 27.02.26 | BASF Buy | Goldman Sachs Group Inc. | |
| 27.02.26 | Alzchem Group Buy | Jefferies & Company Inc. | |
| 27.02.26 | BASF Hold | Jefferies & Company Inc. | |
| 27.02.26 | Delivery Hero Outperform | Bernstein Research | |
| 27.02.26 | London Stock Exchange Overweight | Barclays Capital | |
| 27.02.26 | Eni Overweight | Barclays Capital | |
| 27.02.26 | Scout24 Overweight | Barclays Capital | |
| 27.02.26 | Danone Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.26 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.26 | Lindt Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.26 | Unilever Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.26 | Symrise Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.26 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.26 | Fresenius Medical Care Equal Weight | Barclays Capital | |
| 27.02.26 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 27.02.26 | AIXTRON Overweight | Barclays Capital | |
| 27.02.26 | KION GROUP Overweight | Barclays Capital | |
| 27.02.26 | Fresenius Overweight | Barclays Capital | |
| 27.02.26 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.26 | AIXTRON Buy | Jefferies & Company Inc. | |
| 27.02.26 | AIXTRON Overweight | JP Morgan Chase & Co. | |
| 27.02.26 | Scout24 Overweight | JP Morgan Chase & Co. | |
| 27.02.26 | Scout24 Overweight | JP Morgan Chase & Co. | |
| 27.02.26 | CTS Eventim Overweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.